Biguanides, sulfonylureas/glucosidase inhibitors, and oral hypoglycemic agents such as thiazolidinedione and insulin are used to treat diabetes; however, they cause gastrointestinal side effects such as abdominal pain, diarrhea, and nausea [12,13]. This evidence concerns the gene INS and diabetes mellitus.